Anadrol 50 mg 50 Tablets Saxon Pharma USA
$90.00
Product Short Description
Anadrol 50 mg 50 Tablets Saxon Pharma USA delivers oxymetholone (C21H32O3), the 2-hydroxymethylene-17α-methyl-dihydrotestosterone derivative exhibiting extreme anabolic potency (~320:45 ratio) with rapid mass response, at exact 50 mg strength replicating historical Anadrol-50 formulation. Domestic U.S. production eliminates customs exposure serving DEA Schedule III compliant institutional channels through verified performance networks.
Product Overview
Saxon Pharma USA’s Anadrol 50 mg presents oxymetholone, featuring unique 2α-hydroxymethylene substitution conferring unparalleled oral bioavailability (~8-9 hour half-life) and erythropoietic stimulation alongside profound protein synthesis, in white round scored tablets precisely matching Anadrol-50 (Alaven) morphology for institutional catalog integration across DEA-registered platforms. The 50-tablet HDPE bottle configuration supports CIII-compliant inventory reconciliation under 21 CFR 1304.22 requiring detailed Schedule III tracking for institutional handlers maintaining federal compliance.
U.S.-domiciled GMP manufacturing maintains molecular specifications (MW 332.48) matching FDA reference standards while distinguishing legitimate Schedule III pedigree from underground powder conversions exhibiting 60-80% under-dosing. This authentic prescription-equivalent presentation serves advanced institutional buyers requiring verified batch traceability through serialized lot numbering essential for Form 222 triplicate documentation.
Saxon Anadrol positions exclusively within verified DEA Schedule III ecosystems targeting licensed institutional clientele under 21 CFR 1301.13 registrant requirements.
Brand & Manufacturer Information
Saxon Pharma USA manufactures DEA Schedule III controlled substances through domestic GMP facilities serving institutional performance networks requiring DEA registrant verification. Anadrol 50 mg anchors Saxon’s extreme oral anabolic catalog alongside Dbol/Oxy maintaining historical 50 mg standardization while authenticating supply chain legitimacy versus powder-pressed alternatives rejected by institutional handlers.
Domestic climate-controlled warehousing supports Form 222 platforms eliminating customs risk while serialized batch documentation verifies 50 mg potency through independent HPLC assay distinguishing Saxon from non-pharmaceutical origins.
Active Compound Information
Contains oxymetholone (17α-methyl-2-hydroxymethylene-5α-androstan-3-one), exhibiting 2α-hydroxymethylene modification conferring unprecedented anabolic:androgenic activity characteristic of 17α-alkylated DHT derivatives with exceptional oral absorption. DEA Schedule III classification reflects profound hepatotoxicity, water retention, erythropoiesis stimulation, and cardiovascular risk profile.
50 mg strength precisely matches historical Anadrol-50 (NDC 68220-0055-10) reference while 50-tablet count supports institutional packaging. Molecular formula C21H32O3; WADA S1.1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Anadrol 50 mg 50 Tablets Saxon Pharma USA |
| Active Compound | Oxymetholone (C21H32O3) |
| Strength | 50 mg per white round scored tablet |
| Quantity | 50 tablets per HDPE bottle |
| Form | Oral scored tablets (Anadrol equivalent) |
| Category | DEA Schedule III controlled substance |
| Appearance | White, round, single-scored |
| Molecular Weight | 332.48 g/mol |
| Half-Life | ~8-9 hours |
| Label Elements | “50 mg”, CIII warnings, serialized lot |
Quality Control & Testing Standards
50 mg oxymetholone mandates USP <621> potency assay (HPLC 95-105%), USP <711> dissolution, USP <905> uniformity, and hydroxymethylene verification confirming pharmaceutical-grade specifications matching Anadrol monographs. Saxon batch records document C21H32O3 identity distinguishing GMP production from underground conversions.
50-tablet CIII configuration incorporates USP <671> HDPE barriers with child-resistant closure satisfying 21 CFR 310.310(a). Stability maintains ICH Q1A(R2) 24-month shelf-life.
Intended Use & Market Positioning
Anadrol 50 mg serves DEA-registered CIII institutional researchers managing extreme Schedule III anabolic inventories through encrypted fulfillment requiring Form 222 accountability.
Zero protocols, cycles, or outcomes represented maintaining commercial CIII positioning.
Legal & Regulatory Disclaimer
Oxymetholone constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act (5 years/$250,000 penalties). Institutional buyers assume Form 222/DEA licensing liability; no medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.